🇺🇸 Measles Mumps and Rubella Vaccine in United States

25 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Upper Respiratory Tract Infection — 5 reports (20%)
  2. Pyrexia — 3 reports (12%)
  3. Vaccination Complication — 3 reports (12%)
  4. Abnormal Behaviour — 2 reports (8%)
  5. Arthralgia — 2 reports (8%)
  6. Condition Aggravated — 2 reports (8%)
  7. Contraindication To Vaccination — 2 reports (8%)
  8. Convulsion — 2 reports (8%)
  9. Drug Exposure During Pregnancy — 2 reports (8%)
  10. Drug Ineffective — 2 reports (8%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is Measles Mumps and Rubella Vaccine approved in United States?

Measles Mumps and Rubella Vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Measles Mumps and Rubella Vaccine in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.